Genome Institute of Singapore, Undisclosed Pharma to Use Illumina's BeadChip

Nov 16, 2006

NEW YORK (GenomeWeb News) — The Genome Institute of Singapore will use Illumina's BeadChip technology to analyze 3,000 samples, Illumina said today.

The Institute will work with an undisclosed pharmaceutical company as they use Illumina’s HumanRef-8 Expression. No other information was provided.

Illumina said the technology enables researchers to perform genome-wide expression profiles on eight samples on a single microarray.

The GIS said it liked that the BeadChips are from the same beadpool, which they claimed creates uniform data.

Financial terms of the agreement were not disclosed.

Filed under

Microarrays & Multiplexing

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.